• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码RNA TRIM52-AS1的下调在肾细胞癌中发挥肿瘤抑制作用。

Downregulation of long non-coding RNA TRIM52-AS1 functions as a tumor suppressor in renal cell carcinoma.

作者信息

Liu Zan, Yan Hai-Yan, Xia Shun-Yao, Zhang Cheng, Xiu You-Cheng

机构信息

Department of Urology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.

出版信息

Mol Med Rep. 2016 Apr;13(4):3206-12. doi: 10.3892/mmr.2016.4908. Epub 2016 Feb 18.

DOI:10.3892/mmr.2016.4908
PMID:26934858
Abstract

Long non-coding RNAs (lncRNAs) are important regulators of gene expression, interacting with the major pathways of cell growth, proliferation, differentiation and survival. Alterations in the function of lncRNAs promote tumor formation, progression and metastasis. The purpose of the present study was to identify novel tumor suppressor lncRNAs, and elucidate their physiological function and mechanism in renal cell carcinoma (RCC). The results of the present study revealed that the expression of the lncRNA, TRIM52‑AS1, was downregulated in RCC, which was demonstrated using reverse transcription‑quantitative polymerase chain reaction analysis. Furthermore, the effects of TRIM52‑AS1 on proliferation, cell migration and apoptosis were analyzed using a wound scratch assay, a 3‑(4,5‑dimethylthiazol‑2yl)‑2,5‑diphenyl tetrazolium bromide assay and flow cytometric analysis, respectively. The overexpression of TRIM52‑AS1 using a synthesized vector significantly suppressed cell migration and proliferation, and induced apoptosis of the RCC cells in vitro, and interference of its expression led to the opposite effects. The present study was the first, to the best of our knowledge, to demonstrate that TRIM52‑AS1 functions as a tumor suppressor in RCC. Further investigation is required to elucidate the molecular mechanisms underlying the effects of TRIM52-AS1 in the development of RCC.

摘要

长链非编码RNA(lncRNAs)是基因表达的重要调节因子,与细胞生长、增殖、分化和存活的主要途径相互作用。lncRNAs功能的改变促进肿瘤的形成、进展和转移。本研究的目的是鉴定新的肿瘤抑制性lncRNAs,并阐明它们在肾细胞癌(RCC)中的生理功能和机制。本研究结果显示,lncRNA TRIM52-AS1在RCC中的表达下调,这通过逆转录定量聚合酶链反应分析得以证实。此外,分别使用划痕试验、3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐试验和流式细胞术分析了TRIM52-AS1对增殖、细胞迁移和凋亡的影响。使用合成载体过表达TRIM52-AS1可显著抑制体外RCC细胞的迁移和增殖,并诱导其凋亡,而干扰其表达则产生相反的效果。据我们所知,本研究首次证明TRIM52-AS1在RCC中发挥肿瘤抑制作用。需要进一步研究以阐明TRIM52-AS1在RCC发生发展中作用的分子机制。

相似文献

1
Downregulation of long non-coding RNA TRIM52-AS1 functions as a tumor suppressor in renal cell carcinoma.长链非编码RNA TRIM52-AS1的下调在肾细胞癌中发挥肿瘤抑制作用。
Mol Med Rep. 2016 Apr;13(4):3206-12. doi: 10.3892/mmr.2016.4908. Epub 2016 Feb 18.
2
Identification of long-non coding RNA UCA1 as an oncogene in renal cell carcinoma.长链非编码RNA UCA1作为肾细胞癌致癌基因的鉴定。
Mol Med Rep. 2016 Apr;13(4):3326-34. doi: 10.3892/mmr.2016.4894. Epub 2016 Feb 16.
3
LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.长链非编码RNA TP73-AS1通过抑制KISS1表达及PI3K/Akt/mTOR信号通路失活促进透明细胞肾细胞癌的细胞增殖并抑制细胞凋亡。
Cell Physiol Biochem. 2018;48(1):371-384. doi: 10.1159/000491767. Epub 2018 Jul 17.
4
Overexpression of long non-coding RNA differentiation antagonizing non-protein coding RNA inhibits the proliferation, migration and invasion and promotes apoptosis of renal cell carcinoma.长链非编码 RNA 分化拮抗非编码 RNA 的过表达抑制肾细胞癌的增殖、迁移和侵袭,促进细胞凋亡。
Mol Med Rep. 2017 Oct;16(4):4463-4468. doi: 10.3892/mmr.2017.7135. Epub 2017 Aug 2.
5
High expression of the long non-coding RNA HEIRCC promotes Renal Cell Carcinoma metastasis by inducing epithelial-mesenchymal transition.长链非编码RNA HEIRCC的高表达通过诱导上皮-间质转化促进肾细胞癌转移。
Oncotarget. 2017 Jan 24;8(4):6555-6563. doi: 10.18632/oncotarget.14149.
6
Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137.长链非编码 RNA ZFPM2-AS1 通过靶向 miR-137 促进肾细胞癌的肿瘤发生。
Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5675-5681. doi: 10.26355/eurrev_201907_18304.
7
Identification of miR‑130b as an oncogene in renal cell carcinoma.鉴定miR-130b为肾细胞癌中的一种癌基因。
Mol Med Rep. 2016 Feb;13(2):1902-8. doi: 10.3892/mmr.2015.4744. Epub 2015 Dec 30.
8
Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma.长链非编码 RNA ENSG00000241684 的下调与晚期透明细胞肾细胞癌的不良预后相关。
Eur J Surg Oncol. 2018 Jun;44(6):840-846. doi: 10.1016/j.ejso.2018.01.013. Epub 2018 Jan 13.
9
Long non-coding RNA Z38 promotes cell proliferation and metastasis in human renal cell carcinoma.长非编码 RNA Z38 促进人肾透明细胞癌的增殖和转移。
Mol Med Rep. 2017 Oct;16(4):5489-5494. doi: 10.3892/mmr.2017.7218. Epub 2017 Aug 10.
10
MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.微小RNA-106b通过影响细胞增殖、迁移和凋亡在肾细胞癌中发挥癌基因作用。
Mol Med Rep. 2016 Feb;13(2):1420-6. doi: 10.3892/mmr.2015.4656. Epub 2015 Dec 8.

引用本文的文献

1
The roles of long non‑coding RNAs in renal cell carcinoma (Review).长链非编码RNA在肾细胞癌中的作用(综述)
Mol Clin Oncol. 2022 Nov 28;18(1):4. doi: 10.3892/mco.2022.2600. eCollection 2023 Jan.
2
miR-96-5p regulates cervical cancer cell resistance to cisplatin by inhibiting lncRNA TRIM52-AS1 and promoting IGF2BP2.微小RNA-96-5p通过抑制长链非编码RNA TRIM52-AS1并促进胰岛素样生长因子2结合蛋白2来调节宫颈癌细胞对顺铂的耐药性。
Kaohsiung J Med Sci. 2022 Dec;38(12):1178-1189. doi: 10.1002/kjm2.12593. Epub 2022 Nov 10.
3
() promotes proliferation, migration, and regulation of colon cancer cells associated with the NF-κB signaling pathway.
()促进与NF-κB信号通路相关的结肠癌细胞的增殖、迁移和调节。
J Gastrointest Oncol. 2022 Jun;13(3):1097-1111. doi: 10.21037/jgo-22-317.
4
Potential lncRNA Biomarkers for HBV-Related Hepatocellular Carcinoma Diagnosis Revealed by Analysis on Coexpression Network.基于共表达网络分析筛选出的乙型肝炎病毒相关肝细胞癌潜在长链非编码 RNA 标志物
Biomed Res Int. 2021 Oct 15;2021:9972011. doi: 10.1155/2021/9972011. eCollection 2021.
5
Long Noncoding RNA HCG9 Promotes Osteosarcoma Progression through RAD51 by Acting as a ceRNA of miR-34b-3p.长链非编码 RNA HCG9 通过作为 miR-34b-3p 的 ceRNA 促进骨肉瘤的进展。
Mediators Inflamm. 2021 Aug 18;2021:9978882. doi: 10.1155/2021/9978882. eCollection 2021.
6
Long Non-Coding RNA TRIM52-AS1 Promotes Growth and Metastasis via miR-218-5p/ROBO1 in Hepatocellular Carcinoma.长链非编码RNA TRIM52-AS1通过miR-218-5p/ROBO1促进肝细胞癌的生长和转移
Cancer Manag Res. 2021 Jan 22;13:547-558. doi: 10.2147/CMAR.S286205. eCollection 2021.
7
Identification of a Six-lncRNA Signature With Prognostic Value for Breast Cancer Patients.一种对乳腺癌患者具有预后价值的六lncRNA特征的鉴定。
Front Genet. 2020 Jul 24;11:673. doi: 10.3389/fgene.2020.00673. eCollection 2020.
8
Renal Cell Tumors: Uncovering the Biomarker Potential of ncRNAs.肾细胞肿瘤:揭示非编码RNA的生物标志物潜力
Cancers (Basel). 2020 Aug 7;12(8):2214. doi: 10.3390/cancers12082214.
9
Co-expression analysis and ceRNA network reveal eight novel potential lncRNA biomarkers in hepatocellular carcinoma.共表达分析和ceRNA网络揭示了肝细胞癌中八个新的潜在lncRNA生物标志物。
PeerJ. 2019 Dec 2;7:e8101. doi: 10.7717/peerj.8101. eCollection 2019.
10
Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.基于六个长链非编码 RNA 风险评分的透明细胞肾细胞癌 (ccRCC) 预后:基于 RNA 测序数据的研究。
J Transl Med. 2019 Aug 23;17(1):281. doi: 10.1186/s12967-019-2032-y.